CIK 0000879169
- Large accelerated filer
INCYTE CORP
Sign in to watch- Ticker
- INCY
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943136539
- Phone
- +1 302-498-6700
- Business address
- 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
- Former names
- INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
- 4 Planned sale EVP & General Counsel sold 277 shares at $85.13 ($23,581)
- 4 Planned sale EVP & General Counsel sold 4,100 shares at an average $85.85 ($351,978)
- 4 Shares withheld for taxes EVP & Chief Scientific Officer gave up 1,569 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Head of Incyte Intl gave up 463 shares (to pay taxes)
- 4 Grant or award Director acquired 776 shares (grant or award)
- 4 Grant or award Director acquired 285 shares (grant or award)
- 4 Grant or award Director acquired 289 shares (grant or award)
- 4 Grant or award EVP, Chief Strategy Officer acquired 9,429 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale EVP & General Counsel sold 278 shares at $83.15 ($23,116)
- 4 Planned sale EVP & General Counsel sold 598 shares at $84.97 ($50,812)
- 4 Grant or award EVP, Human Resources acquired 6,506 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale EVP & General Counsel sold 277 shares at $86.81 ($24,046)
- 4 Planned sale EVP & General Counsel sold 598 shares at $75.77 ($45,310)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale EVP & Chief Medical Officer sold 3,706 shares at $67.94 ($251,786)
- 4 Planned sale EVP & General Manager US sold 1,340 shares at $68.36 ($91,602)
- 4 Planned sale EVP, GMAPPS sold 983 shares at $68.36 ($67,198)
- 4 Planned sale EVP & General Counsel sold 4,115 shares at an average $69.57 ($286,296)
Page 6 of 82 · 1,628 filings